BioNTech Investor Presentation Deck

2021: A Year of Transformation & Progress 9 H Expansion of oncology pipeline Expansion of R&D and production teams Production capacity Global presence Commercial infrastructure 1 As of December 31, 2021, BioNTech Group; R&D: Research & development Nine oncology clinical trials started; clinical results from six phase 1 studies Increased R&D and production teams to >2,000 professionals ¹ Expansion of commercial scale mRNA production and addition of US cell therapy manufacturing facility Established offices in Singapore, China and Turkey Deployed commercial team in Germany BIONTECH

View entire presentation